Psikiyatri

Joung KW, Park DH, Jeong CY, Yang HS. Anesthetic care for electroconvulsive therapy. AnesthPainMed (Seoul). 2022;17(2):145-56.

Subramanian S, Lopez R, Zorumski CF, Cristancho P. Electroconvulsive therapy in treatment resistant depression. J Neurol Sci. 2022;434:120095.

Payne NA, Prudic J. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract. 2009;15(5):346-68.

Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017;61(5):373-80.

Jildenstål P, Nordenskjöld A, Edström M, Otterbeck A. Depth of anaesthesia measured by Patient State Index (PSi) does not correlate with ıncreased seizure duration during electroconvulsive therapy. Acta Anaesthesiol Scand. 2026;70(1):e70152.

Reasoner J, Rondeau B. Anesthetic considerations in electroconvulsive therapy. 2023 Aug 5. In: Sta tPearls. Treasure Island (FL): Stat Pearls Publishing; 2025 Jan–. PMID: 35015456

Jindal S, Sidhu GK, Kumari S, Kamboj P, Chauhan R. Etomidate versus propofol for motor seizure duration during modified electroconvulsive therapy. Anesth Essays Res. 2020;14(1):62-7

Czerwonka B, Johnston J, Smith-Steinert R. Anesthesia management for electroconvulsive therapy. AANA J. 2024;92(1):51-6.

Thirthalli J, Sinha P, Sreeraj VS. Clinical practice guidelines for the use of electroconvulsive therapy. Indian J Psychiatry. 2023;65(2):258-69.

Ross L. Electroconvulsivetherapy. In: Urman R, Gross WL, Philip BK, editors. Anesthesia Outside of the Operating Room. 1st ed. New York: Oxford University Press; 2011. pp. 251–9.

Lee K, Jenkins KD, Sparkle T. A Narrative overview of current anesthetic drugs in electroconvulsive therapy. Life (Basel). 2021;11(9):981.

Dai X, Zhang R, Deng N, Tang L, Zhao B. Anesthetic ınfluence on electroconvulsive therapy: a comprehensive review. Neuropsychiatr Dis Treat. 2024;20:1491-502

Jarineshin H, Kashani S, Fekrat F, Vatankhah M, Golmirzaei J, Alimolaee E, et al. Seizure duration and hemodynamic state during electroconvulsive therapy: sodium thiopental versus propofol. Glob J HealthSci. 2015;8(2):126-31.

Kumar A, Sharma DK, Mani R. A comparison of propofol and thiopentone for electroconvulsivetherapy. J Anaesthesiol Clin Pharmacol. 2012;28(3):353-7.

Rajpurohit V, Chaudhary K, Kishan R, Kumari K, Sethi P, Sharma A. Bi-Spectral ındex-guided comparison of propofol versus etomidate for ınduction in electroconvulsive therapy. Anesth Essays Res. 2020;14(3):504-9.

Huang XB, Zheng W. Ketamine and electroconvulsive therapy for treatment-refractory depression. Alpha Psychiatry. 2023;24(6):244-6.

Shen J, Zhou M, Zhu G, Zhang Y, Ma J, Li D, et al. Dexmedetomidine for modified electroconvulsivetherapy: a dose-optimized treatment study. Eur J MedRes. 2025;30(1):241.

Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsivetherapy: implications for drug choice and patient management. CNS Drugs. 2002;16(4):229-47.

Janjua AU, Dhingra AL, Greenberg R, McDonald WM. The efficacy and safety of concomitant psychotropic medicationand electroconvulsive therapy (ECT). CNS Drugs. 2020;34(5):509-20.

Rosenbaum HK, Van den Eynde V, Gillman PK. Expert opinion on anesthetic considerations for patients receiving a classic monoamine oxidase ınhibitor. Anesth Analg. 2024;139(4):863-6.

Zolezzi M. Medication management during electroconvulsanttherapy. Neuropsychiatr Dis Treat. 2016;12:931-9.

Anand R, Nag DS, Gope RL, Sahoo MK, Bhushan P, Pal BD, et al. Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsivetherapy: A meta-analysis. World J Psychiatry. 2026;16(2):112462.

Wolkenstein K, Ali S, Chacko R, Nabi Q, Carter L. Rocuronium-sugammadex and ıntubation used for an electroconvulsive therapy patient. J ECT. 2020;36(2):e15-e16.

Oflezer C, Atay Ö, Kaşdoğan ZE, Özakay G, İpekçioğlu D, Bahadır H. Does the use of rocuronium-sugammadex ınstead of succinylcholine in electroconvulsive therapy affect seizure duration? Psychiatry Investig. 2022;19(10):824-31.

Thirthalli J, Sinha P, Sreeraj VS. Clinical practice guidelines for the use of electroconvulsive therapy. Indian J Psychiatry. 2023;65(2):258-69.

Haghighi M, Sedighinejad A, Naderi Nabi B, Emiralavi C, Biazar G, Mirmozaffari K, et al. The ıncidence and predictors of headache and myalgia in patients after electroconvulsive therapy (ECT). Anesth Pain Med. 2016;6(3):e33724.

Andrade C, Arumugham SS, Thirthalli J. Adverse effects of electroconvulsive therapy. Psychiatr Clin North Am. 2016;39(3):513-30.

Andrade C. Skeletal and dental fractures associated with electroconvulsive therapy. J J Clin Psychiatry. 2023;84(1):23f14797.

Byeon H. Optimizing anesthesia depth to enhance seizure quality during electroconvulsive therapy in major depressive disorder. World J Psychiatry. 2024;14(12):1788-92

Joung KW, Park DH, Jeong CY, Yang HS. Anesthetic care for electroconvulsive therapy. AnesthPainMed (Seoul). 2022;17(2):145-56.

Subramanian S, Lopez R, Zorumski CF, Cristancho P. Electroconvulsive therapy in treatment resistant depression. J Neurol Sci. 2022;434:120095.

Payne NA, Prudic J. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract. 2009;15(5):346-68.

Kadiyala PK, Kadiyala LD. Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian J Anaesth. 2017;61(5):373-80.

Jildenstål P, Nordenskjöld A, Edström M, Otterbeck A. Depth of anaesthesia measured by Patient State Index (PSi) does not correlate with ıncreased seizure duration during electroconvulsive therapy. Acta Anaesthesiol Scand. 2026;70(1):e70152.

Reasoner J, Rondeau B. Anesthetic considerations in electroconvulsive therapy. 2023 Aug 5. In: Sta tPearls. Treasure Island (FL): Stat Pearls Publishing; 2025 Jan–. PMID: 35015456

Jindal S, Sidhu GK, Kumari S, Kamboj P, Chauhan R. Etomidate versus propofol for motor seizure duration during modified electroconvulsive therapy. Anesth Essays Res. 2020;14(1):62-7

Czerwonka B, Johnston J, Smith-Steinert R. Anesthesia management for electroconvulsive therapy. AANA J. 2024;92(1):51-6.

Thirthalli J, Sinha P, Sreeraj VS. Clinical practice guidelines for the use of electroconvulsive therapy. Indian J Psychiatry. 2023;65(2):258-69.

Ross L. Electroconvulsivetherapy. In: Urman R, Gross WL, Philip BK, editors. Anesthesia Outside of the Operating Room. 1st ed. New York: Oxford University Press; 2011. pp. 251–9.

Lee K, Jenkins KD, Sparkle T. A Narrative overview of current anesthetic drugs in electroconvulsive therapy. Life (Basel). 2021;11(9):981.

Dai X, Zhang R, Deng N, Tang L, Zhao B. Anesthetic ınfluence on electroconvulsive therapy: a comprehensive review. Neuropsychiatr Dis Treat. 2024;20:1491-502

Jarineshin H, Kashani S, Fekrat F, Vatankhah M, Golmirzaei J, Alimolaee E, et al. Seizure duration and hemodynamic state during electroconvulsive therapy: sodium thiopental versus propofol. Glob J HealthSci. 2015;8(2):126-31.

Kumar A, Sharma DK, Mani R. A comparison of propofol and thiopentone for electroconvulsivetherapy. J Anaesthesiol Clin Pharmacol. 2012;28(3):353-7.

Rajpurohit V, Chaudhary K, Kishan R, Kumari K, Sethi P, Sharma A. Bi-Spectral ındex-guided comparison of propofol versus etomidate for ınduction in electroconvulsive therapy. Anesth Essays Res. 2020;14(3):504-9.

Huang XB, Zheng W. Ketamine and electroconvulsive therapy for treatment-refractory depression. Alpha Psychiatry. 2023;24(6):244-6.

Shen J, Zhou M, Zhu G, Zhang Y, Ma J, Li D, et al. Dexmedetomidine for modified electroconvulsivetherapy: a dose-optimized treatment study. Eur J MedRes. 2025;30(1):241.

Naguib M, Koorn R. Interactions between psychotropics, anaesthetics and electroconvulsivetherapy: implications for drug choice and patient management. CNS Drugs. 2002;16(4):229-47.

Janjua AU, Dhingra AL, Greenberg R, McDonald WM. The efficacy and safety of concomitant psychotropic medicationand electroconvulsive therapy (ECT). CNS Drugs. 2020;34(5):509-20.

Rosenbaum HK, Van den Eynde V, Gillman PK. Expert opinion on anesthetic considerations for patients receiving a classic monoamine oxidase ınhibitor. Anesth Analg. 2024;139(4):863-6.

Zolezzi M. Medication management during electroconvulsanttherapy. Neuropsychiatr Dis Treat. 2016;12:931-9.

Anand R, Nag DS, Gope RL, Sahoo MK, Bhushan P, Pal BD, et al. Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsivetherapy: A meta-analysis. World J Psychiatry. 2026;16(2):112462.

Wolkenstein K, Ali S, Chacko R, Nabi Q, Carter L. Rocuronium-sugammadex and ıntubation used for an electroconvulsive therapy patient. J ECT. 2020;36(2):e15-e16.

Oflezer C, Atay Ö, Kaşdoğan ZE, Özakay G, İpekçioğlu D, Bahadır H. Does the use of rocuronium-sugammadex ınstead of succinylcholine in electroconvulsive therapy affect seizure duration? Psychiatry Investig. 2022;19(10):824-31.

Thirthalli J, Sinha P, Sreeraj VS. Clinical practice guidelines for the use of electroconvulsive therapy. Indian J Psychiatry. 2023;65(2):258-69.

Haghighi M, Sedighinejad A, Naderi Nabi B, Emiralavi C, Biazar G, Mirmozaffari K, et al. The ıncidence and predictors of headache and myalgia in patients after electroconvulsive therapy (ECT). Anesth Pain Med. 2016;6(3):e33724.

Andrade C, Arumugham SS, Thirthalli J. Adverse effects of electroconvulsive therapy. Psychiatr Clin North Am. 2016;39(3):513-30.

Andrade C. Skeletal and dental fractures associated with electroconvulsive therapy. J J Clin Psychiatry. 2023;84(1):23f14797.

Byeon H. Optimizing anesthesia depth to enhance seizure quality during electroconvulsive therapy in major depressive disorder. World J Psychiatry. 2024;14(12):1788-92